Literature DB >> 19387229

Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in ireland.

Ayman Saeed1, Fiona D'Arcy, Jim Stack, Louis M Collum, William Power, Stephen Beatty.   

Abstract

AIM: To identify the risk factors for, and to report the microbiological findings and clinical outcomes of, severe microbial keratitis (MK).
METHODS: This was a retrospective study of all cases of presumed MK admitted to a tertiary referral center over a 2-year period (September 2001 to August 2003). Data recorded included demographic data, details relating to possible risk factors, results of microbiological studies, clinical findings at presentation, and clinical and visual outcomes.
RESULTS: Ninety patients were admitted with a diagnosis of presumed MK during the study period. The mean age of patients was 45 +/- 32 years, and the male to female ratio was 47:43 (52.2%:47.7%). Predisposing risk factors for MK included contact lens wear (37; 41.1%), anterior segment disease (19; 21.1%), ocular trauma (13; 14.4%), systemic disease (5; 5.6%), and previous ocular surgery (1; 1.1%). Cultured organisms included gram-negative bacteria (17; 51.5%), gram-positive bacteria (11, 33.3%), acanthamoeba (2; 6.1%), and fungi (1; 3%). Visual acuity improved significantly after treatment [mean best-corrected visual acuity (+/-standard deviation) at presentation: 0.76 (+/-0.11); mean best-corrected visual acuity at last follow-up: 0.24 (+/-0.07); P < 0.001]. Secondary surgical procedures were required in 18 (20%) cases, and these included punctal cautery (1; 1.1%), tissue glue repair of corneal perforation (2; 2.2%), tarsorrhaphy (9; 9.9%), Botulinum toxin-induced ptosis (1; 1.1%), penetrating keratoplasty (3; 3.3%), and evisceration (2; 2.2%).
CONCLUSIONS: Contact lens wear remains a significant risk factor for severe MK. MK remains a threat to vision and to the eye, but the majority of cases respond to prompt and appropriate antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387229     DOI: 10.1097/ICO.0b013e3181877a52

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  23 in total

1.  Epidemiological, clinical and laboratory findings of infectious keratitis at Mansoura Ophthalmic Center, Egypt.

Authors:  Amani E Badawi; Dalia Moemen; Nora L El-Tantawy
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

2.  Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Sidney D Taylor; Nathan A Tullos; Rhonda R Caston; Sherrina N Dixon; Moon H Nahm; Robert L Burton; Hilary Thompson; Larry S McDaniel; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

3.  UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.

Authors:  Karim Makdoumi; Jes Mortensen; Omid Sorkhabi; Bo-Eric Malmvall; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-27       Impact factor: 3.117

4.  Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Mary E Marquart
Journal:  J Bacteriol Parasitol       Date:  2011

5.  Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.

Authors:  Erin W Norcross; Nathan A Tullos; Sidney D Taylor; Melissa E Sanders; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

6.  Clinical presentation and morbidity of contact lens-associated microbial keratitis: a retrospective study.

Authors:  Johan G Hoddenbach; Sharmila S Boekhoorn; Rene Wubbels; Willem Vreugdenhil; Jeroen Van Rooij; Annette J M Geerards
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-27       Impact factor: 3.117

7.  [Effectiveness of initial antibiotic therapy for treatment of contact lens-related bacterial keratitis].

Authors:  B Steger; L Speicher; W Philipp; T Gasser; E Schmid; N Bechrakis
Journal:  Ophthalmologe       Date:  2014       Impact factor: 1.059

8.  Management and treatment of contact lens-related Pseudomonas keratitis.

Authors:  Mark Dp Willcox
Journal:  Clin Ophthalmol       Date:  2012-06-18

9.  Results of case-control studies support the association between contact lens use and Acanthamoeba keratitis.

Authors:  Elena Pacella; Giuseppe La Torre; Maria De Giusti; Chiara Brillante; Anna Maria Lombardi; Gianpaolo Smaldone; Tommaso Lenzi; Fernanda Pacella
Journal:  Clin Ophthalmol       Date:  2013-05-28

10.  Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases.

Authors:  Jorge L Alio; Alessandro Abbouda; David Diaz Valle; Jose M Benitez Del Castillo; Jose A Gegundez Fernandez
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.